gabexate has been researched along with allopurinol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 6 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirano, T; Manabe, T | 1 |
| Andoh, K; Kyogoku, T; Manabe, T; Oshio, G; Tamura, K; Tobe, T | 1 |
| Manabe, T; Tamura, K; Tobe, T | 1 |
| Higashimoto, Y; Kawamoto, H; Kuroshima, T; Tsuji, K; Yamasaki, Y | 1 |
| Hamamoto, I; Hossain, MA; Izuishi, K; Maeba, T; Maeta, H; Okano, K | 1 |
| Thom, SR | 1 |
| Hamamoto, I; Hossain, MA; Maeba, T; Maeta, H; Okada, S; Okano, K; Wakabayashi, H | 1 |
| Amano, H; Arata, S; Gabata, T; Hirata, K; Hirota, M; Ito, T; Kataoka, K; Kimura, Y; Kiriyama, S; Mayumi, T; Sekimoto, M; Takada, T; Takeda, K; Tanaka, M; Wada, K; Yokoe, M; Yoshida, M | 1 |
8 other study(ies) available for gabexate and allopurinol
| Article | Year |
|---|---|
"Cocktail" therapy for acute pancreatitis: combined therapy of protease inhibitor, xanthine oxidase inhibitor and platelet activating factor antagonist in rat caerulein-induced pancreatis.
Topics: Acute Disease; Allopurinol; Animals; Ceruletide; Drug Therapy, Combination; Gabexate; Male; Pancreatitis; Platelet Activating Factor; Pyridinium Compounds; Rats; Rats, Wistar; Xanthine Oxidase | 1992 |
Effect of intraarterial active oxygen species on the rat pancreas.
Topics: Amylases; Animals; Ascitic Fluid; Catalase; Free Radicals; Gabexate; Hydrogen Peroxide; Infusions, Intravenous; Injections, Intra-Arterial; Lipase; Male; Pancreas; Rats; Rats, Inbred Strains; Superoxide Dismutase; Superoxides; Xanthine; Xanthine Oxidase; Xanthines | 1992 |
[Effect of oxygen free radicals on the rat pancreas in vivo].
Topics: Acute Disease; Animals; Catalase; Free Radical Scavengers; Free Radicals; Gabexate; Hydrogen Peroxide; Male; Oxygen; Pancreas; Pancreatitis; Rats; Rats, Inbred Strains; Superoxide Dismutase; Xanthine; Xanthine Oxidase; Xanthines | 1991 |
[Protective effect of camostat mesilate and allopurinol in acute edematous pancreatitis in the rat induced by excessive doses of caerulein].
Topics: Acute Disease; Allopurinol; Animals; Ceruletide; Edema; Esters; Gabexate; Guanidines; Male; Pancreatitis; Rats; Rats, Inbred Strains; Trypsin Inhibitors | 1987 |
Deleterious effect of cold preservation of rat liver on the early phase of reperfusion with special reference to tissue circulation and cytokine release.
Topics: Adenosine; Allopurinol; Analysis of Variance; Animals; Antibodies, Monoclonal; Bile; Blood; Cold Temperature; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Gabexate; Glutathione; Insulin; Intercellular Adhesion Molecule-1; L-Lactate Dehydrogenase; Liver; Liver Circulation; Lymphocyte Function-Associated Antigen-1; Male; Organ Preservation; Organ Preservation Solutions; Raffinose; Rats; Rats, Inbred Lew; Regional Blood Flow; Reperfusion; Tumor Necrosis Factor-alpha | 1995 |
Leukocytes in carbon monoxide-mediated brain oxidative injury.
Topics: Allopurinol; Animals; Brain; Carbon Monoxide Poisoning; Cell Adhesion; Gabexate; Leukocytes; Leukopenia; Male; Microcirculation; Oxidation-Reduction; Peroxidase; Protease Inhibitors; Rats; Rats, Wistar; Xanthine Dehydrogenase; Xanthine Oxidase | 1993 |
Ameliorative effect of gabexate mesilate on the disturbed microcirculation following prolonged cold ischemia of the liver.
Topics: Adenosine; Allopurinol; Analysis of Variance; Animals; Anticoagulants; Bile; Cold Temperature; Gabexate; Glutathione; Insulin; Ischemia; L-Lactate Dehydrogenase; Liver; Liver Transplantation; Male; Microcirculation; Organ Preservation; Organ Preservation Solutions; Portal System; Raffinose; Rats; Rats, Inbred Lew; Regional Blood Flow; Reperfusion; Reperfusion Injury; Time Factors | 1996 |
Post-ERCP pancreatitis.
Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Cholangiopancreatography, Endoscopic Retrograde; Gabexate; Hormones; Humans; Hydrazones; Immunosuppressive Agents; Meta-Analysis as Topic; Pancreatitis; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Factors; Somatostatin; Stents | 2010 |